Azura Ophthalmics   Report issue

For profit Phase 3
Founded: Tel Aviv Israel (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2018
NCT03652051
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Azura Ophthalmics